In 2019, pharmaceutical companies began to raise prices for more than 250 pharmaceutical products in the United States, including the world’s best-selling homera drug. According to data from Rex Savings Solutions, which helps health programs and employers search for less expensive drugs, the average increase on hundreds of pharmaceutical products was about 6.3 percent.
The increases are up to 10 percent on nearly 20 pharmaceutical products. The increases come despite expectations by US President Donald Trump on Wednesday that drug prices will fall.
Reuters reported late last year that some 30 pharmaceutical companies had told California agencies that they intended to raise the price of the drug. Pfizer already announced its plans later this month to resume its practice of raising drug prices and raising the price list for 41 drugs.
The company had retreated last summer from applying after increases due to pressure from President Trump. Despite the increases, it is a third less than last year’s increases, according to RexSevens Solutions.